An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

NCT01273454 · clinicaltrials.gov ↗

COMPLETED

Status

648

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: OROS Hydromorphone

Sponsor

Janssen Korea, Ltd., Korea